FDA Inspection
New York Blood Center EnterprisesNew York Blood Center Enterprises – FDA Inspection, Feb 11, 2020
Record Details
This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on February 11, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- February 11, 2020
- Product Type
- Biologics
View Company Profile
ID · d7c05152-a755-44b7-acb6-8b9840cbb679
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1118178
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center Enterprises
13| Date | Classification | Office | Project area |
|---|---|---|---|
| April 3, 2026 | Not classified | New York District Office | Blood and Blood Products |
| September 24, 2025 | VAI | New York District Office | Blood and Blood Products |
| September 7, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 7, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 22, 2017 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for New York Blood Center Enterprises
- FDA Inspection 1311062 - 2026-04-03
- FDA Inspection 1283668 - 2025-09-24
- FDA Inspection 1217513 - 2023-09-07
- FDA Inspection 1064704 - 2018-08-07
- FDA Inspection 1036848 - 2017-11-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.